NutriBand (NTRB) Interest & Investment Income (2019 - 2026)
NutriBand (NTRB) posted Interest & Investment Income of $58190.0 for Q1 2026, up 330.49% sequentially from $13517.0 in Q4 2025, and up 26.27% YoY from $46084.0 in Q1 2025.
NutriBand (NTRB) Interest & Investment Income (2019 - 2026) Analysis & Trends
NutriBand has reported Interest & Investment Income for 8 years, with the latest figure at $58190.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 26.27% year-over-year to $58190.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $110864.0 (down 42.16% YoY) and the FY2026 annual result came in at $110864.0, down 42.16% from the prior year.
- Interest & Investment Income grew to $58190.0 in Q1 2026 per NTRB's latest filing, from $13517.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $77332.0 in Q3 2024 and troughed at -$3.8 million in Q1 2022.
- A 5-year average of -$345180.4 and a median of $5815.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income sank 119.0% in 2022, then jumped 169388.89% in 2025.
- Over 5 years, Interest & Investment Income stood at -$1.0 million in 2022, then jumped by 100.36% to $3765.0 in 2023, then jumped by 1712.35% to $68235.0 in 2024, then slumped by 80.19% to $13517.0 in 2025, then soared by 330.49% to $58190.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $58190.0, $13517.0, and $8649.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 58,190.00 |
| Oct 31, 2025 | 13,517.00 |
| Jul 31, 2025 | 8,649.00 |
| Apr 30, 2025 | 30,508.00 |
| Jan 31, 2025 | 46,084.00 |
| Oct 31, 2024 | 68,235.00 |
| Jul 31, 2024 | 77,332.00 |
| Apr 30, 2024 | 18.00 |
| Jan 31, 2024 | 3,020.00 |
| Oct 31, 2023 | 3,765.00 |
| Jul 31, 2023 | 4,250.00 |
| Apr 30, 2023 | 5,815.00 |
| Jul 31, 2022 | -1.04 Mn |
| Apr 30, 2022 | -689,989.00 |
| Jan 31, 2022 | -3.77 Mn |
| Oct 31, 2021 | -1.77 Mn |
| Jul 31, 2021 | -519,923.00 |
| Apr 30, 2021 | -315,057.00 |
| Jan 31, 2021 | -2.25 Mn |
| Oct 31, 2020 | -42,569.00 |